Vinflunine and Areas for Improvement in the Management of Urothelial Carcinoma
Welcome to the supplement, Vinflunine and Areas for Improvement in the Management of Urothelial Carcinoma, accompanying the winter 2013 edition of European Oncology & Haematology. The supplement includes five insightful review articles focusing on vinflunine in the management of urothelial carcinoma. This particular malignancy is a worthy focus for the supplement as there has been no improvement in survival rates over the past few decades and therapeutic options are limited. The expert authors provide enlightening and thought-provoking articles for our perusal. Please enjoy the knowledgeable content and we welcome your feedback.